Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray… - … England Journal of …, 2012 - Mass Medical Soc
Background This study was undertaken to determine whether use of the direct renin inhibitor
aliskiren would reduce cardiovascular and renal events in patients with type 2 diabetes and …
aliskiren would reduce cardiovascular and renal events in patients with type 2 diabetes and …
[HTML][HTML] Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes
JJ Park - Diabetes & metabolism journal, 2021 - synapse.koreamed.org
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus
(DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with …
(DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with …
2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart …
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …
introduction of effective new therapies that potentially affect a large number of patients …
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
M Brunström, B Carlberg - bmj, 2016 - bmj.com
Objective To assess the effect of antihypertensive treatment on mortality and cardiovascular
morbidity in people with diabetes mellitus, at different blood pressure levels. Design …
morbidity in people with diabetes mellitus, at different blood pressure levels. Design …
[HTML][HTML] Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology-2019
DB Precoma, GMM Oliveira, AF Simao… - Arquivos brasileiros de …, 2019 - SciELO Brasil
Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …
Oxidative stress and heart failure
H Tsutsui, S Kinugawa… - American journal of …, 2011 - journals.physiology.org
Oxidative stress, defined as an excess production of reactive oxygen species (ROS) relative
to antioxidant defense, has been shown to play an important role in the pathophysiology of …
to antioxidant defense, has been shown to play an important role in the pathophysiology of …
Gender differences in the effects of cardiovascular drugs
An initiation-promotion protocol was used to test the hypothesis that unleaded gasoline (UG)
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and …
C Rosendorff, DT Lackland, M Allison, WS Aronow… - Circulation, 2015 - Am Heart Assoc
(AHA) scientific statement “Treatment of Hypertension in the Prevention and Management of
Ischemic Heart Disease: A Scientific Statement From the American Heart Association …
Ischemic Heart Disease: A Scientific Statement From the American Heart Association …
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
M Volpe, M Carnovali, V Mastromarino - Clinical Science, 2016 - portlandpress.com
After its discovery in the early 1980s, the natriuretic peptide (NP) system has been
extensively characterized and its potential influence in the development and progression of …
extensively characterized and its potential influence in the development and progression of …
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
The prevalence of patients with concomitant heart failure (HF) and diabetes mellitus (DM)
continues to increase with the general aging of the population. In patients with chronic HF …
continues to increase with the general aging of the population. In patients with chronic HF …